A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts.

Stamer, Ulrike M; Schmutz, Maxime; Wen, Tingting; Banz Wüthrich, Vanessa; Lippuner, Christoph; Zhang, Lan; Steffens, Michael; Stüber, Frank (2019). A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts. European journal of anaesthesiology, 36(8), pp. 566-574. Wolters Kluwer 10.1097/EJA.0000000000001014

Text Stamer_Serotonin transporter EJA_2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (240kB)

BACKGROUND

Clinical risk factors for postoperative nausea and vomiting (PONV) are well described, whereas genetic findings are conflicting.

OBJECTIVE

The aim of this study was to investigate a possible association of genetic variants and nongenetic variables with the incidence and severity of PONV.

DESIGN

A prospective observational study in two independent and different patient cohorts.

SETTING

Two independent patient cohorts differing in surgical procedures were enrolled in two tertiary care hospitals between 2008 and 2016.

PATIENTS

Consecutive patients of European origin undergoing elective surgery in two university hospitals. Clinical data were collected up to 24 h after surgery, and blood was drawn for genotyping. Of 2773 patients enrolled, 918 (Cohort A) and 1663 (Cohort B) with complete data sets were analysed.

MAIN OUTCOME MEASURE

Patients were allocated to one of three groups (No PONV, Intermediate PONV or Severe PONV) depending on the frequency of vomiting, the severity of nausea and the need for antiemetics. Clinical variables and 13 genetic variants of seven candidate genes were evaluated for association with these three phenotypes. The cohorts were analysed separately by ordinal logistic regression analysis, treating PONV as a dependent ordinal three-stage variable. Odds ratios (ORs) with 95% confidence intervals were calculated.

RESULTS

In Cohort A, the main predictors for PONV were female sex [OR (95% CI): 3.6 (2.7 to 4.8), P < 0.0001], nonsmoking status 1.8 (1.3 to 2.5), P < 0.001, the SS genotype (5-HTTLPR, rs4795541) of the promoter polymorphism in the serotonin transporter 1.5 (1.1 to 2.1), P = 0.019, and patient age 0.99 (0.98 to 0.99), P = 0.013. Analysis of Cohort B was consistent with these findings [5-HTTLPR: 1.8 (1.4 to 2.3), P < 0.00001]. Sex-specific regression models confirmed this 5-HTTLPR association in women and men.

CONCLUSION

In two independent cohorts, in addition to the well known clinical factors, a polymorphism of 5-HTTLPR in the serotonin transporter was independently associated with PONV. A possible evaluation of this biomarker to improve risk prediction within the scope of precision medicine should be considered.

TRIAL REGISTRATION

Clinicaltrials.gov identifier NCT03490175.

Interest & Impact

Downloads

2 since deposited on 08 Aug 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item